Skip to main content

Intubation

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
CMAC video laryngoscopeN/A1 trial
Active Trials
NCT00956592Completed300Est. Dec 2010
GE HealthCare
1 program
CO2N/A1 trial
Active Trials
NCT06715410Completed42Est. Sep 2024
ETS
ETSMO - Rolla
1 program
Cuffed tracheal tubesN/A1 trial
Active Trials
NCT03129893Completed242Est. Jun 2019
Verathon
VerathonBC - Burnaby
1 program
Laryngoscopy with GlideScopeN/A1 trial
Active Trials
NCT03277872Completed50Est. Jul 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GE HealthCareCO2
VerathonLaryngoscopy with GlideScope
ETSCuffed tracheal tubes
Oregon TherapeuticsCMAC video laryngoscope

Clinical Trials (4)

Total enrollment: 634 patients across 4 trials

Carbon Dioxide Investigation

Start: Jan 2024Est. completion: Sep 202442 patients
N/ACompleted
NCT03277872VerathonLaryngoscopy with GlideScope

NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope

Start: Sep 2017Est. completion: Jul 202150 patients
N/ACompleted
NCT03129893ETSCuffed tracheal tubes

Cuffed Versus Uncuffed Tracheal Tubes in PICU (PICU-BG-TT Study)

Start: Jan 2017Est. completion: Jun 2019242 patients
N/ACompleted
NCT00956592Oregon TherapeuticsCMAC video laryngoscope

Clinical Evaluation of the Storz CMAC Laryngoscope

Start: Oct 2009Est. completion: Dec 2010300 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.